How Bill Gates’ Billions Shape US Medical Research

How Bill Gates’ Billions Shape US Medical Research

Paul Thacker

On the eve of Gates’ private testimony with Congress scheduled for tomorrow, a trove of federal whistleblower documents provided to RealClearInvestigations is renewing questions about how Gates money has bought what critics complain is an untoward influence on government health policy. For almost a quarter of a century, his main vehicle of power, the Bill and Melinda Gates Foundation, has donated hundreds of millions of dollars to the National Institutes of Health (NIH), allowing Gates to shape the direction of the country’s health strategy in ways that have benefitted his own priorities and pet causes while polishing his image as a benevolent global do-gooder.

At a time of growing concern about the power of billionaires such as Elon Musk, Jeff Bezos, and Sam Altman, Gates’ efforts stand out. Instead of lobbying federal agencies for specific policies, Gates leveraged his wealth to work inside the government, partnering with high-ranking NIH officials to steer taxpayer research funding and design scientific policies for several federal programs.

The cache of several dozen emails and documents, made public for the first time by an NIH whistleblower, reinforces previous reports detailing Gates’s extensive influence over U.S. biomedical research. During the height of the CV pandemic, Kate Elder, a senior vaccines policy adviser for Doctors Without Borders, complained to Politico, “What makes Bill Gates qualified to be giving advice and advising the U.S. government on where they should be putting the tremendous resources?”

Emails and internal plans, for example, show that the NIH – the world’s largest funder of biomedical research – gave the Gates Foundation first billing for the joint workshops and meetings held on federal property.

The Gates Foundation did not respond to repeated requests for comment. The NIH also declined to comment.

Like most philanthropies, the Gates Foundation tries to grow its endowment through investments. Some of these efforts, especially its stake in vaccine companies, blur the lines between profit-seeking and the foundation’s mission to develop and deliver vaccines around the world. This symbiotic relationship between capitalism and charity also benefits Gates, whose power and position hinge in large part on the size of his foundation’s assets. Before the pandemic, The Nation magazine reported that the Gates Foundation had a $40 million stake in CureVac – this was not a grant but an investment. CureVac was one of many companies the nonprofit bought stock in that were working on vaccines and therapeutics.

The Bill and Melinda Gates Foundation was established in 2000 with an initial endowment of $20 billion and a primary focus on reducing global health disparities. Rather than working exclusively through non-governmental agencies, the Gates Foundation began contributing to the NIH through the agency’s own nonprofit, the Foundation for the National Institutes of Health (FNIH). Congress created the FNIH in 1990 as a firewall between NIH officials and outside donors seeking to influence federal research.

More...